DocGo Inc DCGO.OQ DCGO.O is expected to show a fall in quarterly revenue when it reports results on May 8 for the period ending March 31 2025
The New York City-based company is expected to report a 45.7% decrease in revenue to $104.248 million from $192.09 million a year ago, according to the mean estimate from 7 analysts, based on LSEG data.
‚ÄčLSEG's mean analyst estimate for DocGo Inc is for a loss of 2 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months. ‚Äč
Wall Street's median 12-month price target for DocGo Inc is $5.00‚Äč, above‚Äč its last closing price of $2.34. ‚Äč‚Äč‚Äč
Previous quarterly performance (using preferred earnings measure in US dollars). ‚Äč
QUARTER ENDING
STARMINESMARTESTIMATE¬ģ
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
0.04
0.05
0.04
Missed
-17.6
Sep. 30 2024
0.04
0.05
0.05
Met
2.9
Jun. 30 2024
0.06
0.08
0.07
Missed
-6.7‚Äč
Mar. 31 2024
0.07
0.08
0.10
Beat
22.8
‚Äč‚ÄčDec. 31 2023
0.09
0.10
0.07
Missed
-30
Sep. 30 2023
0.05
0.06
0.05
Missed
-18.9‚Äč
Jun. 30 2023
0.03
0.03
-0.02
Missed
-166.7
Mar. 31 2023
0.02
0.02
-0.03
Missed
-238.4
This summary was machine generated May 6 at 22:38 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)